Temukan Klinik dan Biaya Terbaik untuk pengobatan Kanker paru-paru di Letónia 2026

Leading hospitals for lung cancer treatment in Latvia include the Latvian Oncology Center and Pauls Stradins Clinical University Hospital. These Riga-based institutions provide tertiary-level care. They specialize in thoracic surgery, advanced diagnostics, and multidisciplinary oncology. Private clinics like Pallas Clinic offer complementary therapies and immunotherapy.

• Surgical expertise: The Latvian Oncology Center performs uniportal video-assisted thoracoscopic surgery (VATS).
• Diagnostic access: Patients often use private centers like Health Center 4 for faster PET scans.
• Integrative oncology: Pallas Clinic in Jurmala combines conventional treatments with advanced medical therapeutic products.
• Specialized immunology: Dr. Inta Jaunalksne at Pallas Clinic has over 30 years of experience.

Bookimed Expert Insight: Patients can bypass long waiting lists by starting diagnostics at private Riga clinics. Bookimed data shows specialists like Dr. Inta Jaunalksne hold dual roles in public and private sectors. Her experience at Pauls Stradins Clinical University Hospital informs the protocols at Pallas Clinic. This crossover ensures private patients receive high-level clinical expertise without the 3-month public system delays.

Patient Consensus: Patients note that while public hospitals in Riga are highly competent, diagnostic bottlenecks are common. Many recommend paying out-of-pocket for initial biopsies or scans to save critical months before starting treatment.

Advanced minimally invasive lung cancer surgeries are available in Latvia through Video-Assisted Thoracic Surgery (VATS) and innovative local destructive therapies. Specialized centers in Riga perform uniportal VATS and robotic radiosurgery. These techniques reduce physical trauma and allow for faster recovery than traditional open chest surgery.

• Video-Assisted surgery: Surgeons perform lobectomies through a single small incision using uniportal VATS.
• Local destructive therapies: Microwave and cryoablation destroy tumors via needles without large incisions.
• Precision radiosurgery: CyberKnife technology provides non-invasive treatment for specific lung tumor cases.
• Recovery timeframe: Patients often leave the hospital within 24 hours after ablation procedures.

Bookimed Expert Insight: While basic VATS is common, complex cases are concentrated in academic centers. Dr. Inta Jaunalksne at Pallas Clinic in Jūrmala provides specialized immunology that can support surgical recovery. Our data indicates patients often combine Latvian surgical expertise with these integrative protocols for personalized care.

Patient Consensus: Patients note that surgeons are honest about their experience levels with advanced techniques. Many suggest confirming the specific number of procedures a surgeon has performed before scheduling surgery.

Standard lung cancer care in Latvia integrates surgery, chemotherapy, and advanced radiation techniques like CyberKnife and proton-beam therapy. Multidisciplinary teams manage treatment protocols. These plans often combine conventional methods with immunotherapy (Pembrolizumab) and targeted therapies. Clinical centers also provide specialized biological treatments like virotherapy.

• Surgical procedures: Lobectomy and pneumonectomy are primary curative options for early-stage cases.
• Advanced radiotherapy: Facilities utilize stereotactic body radiotherapy, CyberKnife, and brachytherapy for precision.
• Drug therapies: Treatment includes cisplatin-based chemotherapy and immunotherapy drugs like Keytruda (Pembrolizumab).
• Biological options: Specialized clinics offer virotherapy and advanced medical therapeutic products (AMTP).
• Alternative methods: Local destructive therapies include microwave ablation and cryoablation for non-surgical candidates.

Bookimed Expert Insight: Patient data shows a distinct focus on immunology and virotherapy in Jūrmala and Riga. Dr. Inta Jaunalksne at Pallas Clinic brings over 30+ years of expertise to these integrative protocols. This specialization attracts patients seeking biological therapies alongside conventional oncology care in Latvia.

Patient Consensus: Patients note that public system wait times can reach 2-3 months. Many recommend budgeting for private services or English translators to navigate the treatment process more efficiently.

Latvia integrates multidisciplinary care for lung cancer through specialized Tumor Boards and structured Cancer Patient Pathways. These teams combine expertise from thoracic surgeons, radiologists, and oncologists to standardize treatment. Approximately 80% of Latvian cancer patients receive this coordinated, specialized medical care.

• Specialist collaboration: Respiratory physicians and medical oncologists review cases during regular meetings.
• Centralized expertise: High-level care is concentrated in tertiary centers like Riga East Hospital.
• Integrative approach: Clinics like Pallas Clinic combine conventional treatments with advanced immunology protocols.
• Clinical pathways: Structured protocols guide patients from initial suspicion through post-treatment rehabilitation.
• International standards: Latvian oncology centers align with European Society for Medical Oncology guidelines.

Bookimed Expert Insight: While major state hospitals focus on standard surgical and radiation protocols, private centers like Pallas Clinic in Jurmala specialize in niche supportive therapies. Dr. Inta Jaunalksne, who has over 30 years of experience, leads immunology efforts there. This allows patients to access specialized virotherapy and customized integrative plans alongside primary treatments. Choosing a facility with both established surgical teams and specialized immunologists provides the most comprehensive care coverage.

Patient Consensus: Patients emphasize the importance of confirming that a full multidisciplinary team reviews their case before starting treatment. They often recommend seeking care at larger teaching hospitals in Riga to ensure access to a wider range of specialists.

Latvia offers access to clinical trials and cutting-edge therapies through the State Agency of Medicines and European Union regulatory frameworks. Patients can access stage IV non-small cell lung cancer trials. Specialized clinics provide advanced immunotherapies, including dendritic cell therapy (DCT) and cytokine-induced killer (CIK) cell treatments.

• Regulatory oversight: The State Agency of Medicines of Latvia regulates all active clinical trials.
• Advanced immunology: Pallas Clinic in Jūrmala offers customized integrative oncology and cellular therapy protocols.
• Expert leadership: Dr. Inta Jaunalksne brings 30+ years of experience in clinical immunology research.
• Molecular diagnostics: Local institutions like the Latvian Biomedical Research Centre support genomic and precision medicine.

Bookimed Expert Insight: While Latvia serves as a growing research hub, patients often face a choice between standard public care and specialized private immunology. Centers like Pallas Clinic emphasize individualized protocols that combine conventional oncology with Advanced Medical Therapeutical Products (AMTP). This integrative approach targets 100+ patients annually who seek alternatives to traditional chemotherapy-only regimens.

Patient Consensus: Patients note that while standard treatments are available, accessing the newest immunotherapy often requires moving to private clinics or traveling to larger EU hubs. Many emphasize that proactive requests are necessary, as local doctors may not always volunteer information about experimental trial options.